Чрезвычайные ситуации возникают по целому ряду причин: природные бедствия, такие как землетрясения и наводнения; вооруженные конфликты и гражданские войны; техно...енные катастрофы, включая радиационные аварии. Вне зависимости от природы пускового фактора результатом часто является череда человеческих страданий. Речь может идти о крупномасштабных вынужденных перемещениях населения, дефиците пищевых продуктов, вспышках болезней, нарушении прав и достоинства человека и смертях.
Путем публикации данных материалов ВОЗ ставит перед собой цель обеспечения того, чтобы в условиях чрезвычайной ситуации не упускались возможности для реформирования системы охраны психического здоровья.
more
Ces formulaires sont destinés uniquement aux cliniciens et infirmiers s’occupant de patients atteints de la maladie à virus Ebola. Ils fournissent des informations standardisées qui doivent être collectées par les cliniciens au moment de l’admission, tous les jours, et lors de la sortie du ...patient.
more
These forms are intended only for clinicians and nurses taking care of patients with Ebola virus disease. They provide standardized information that needs to be collected by the clinicians at admission time, every day and at time of discharge.
The 2014-2015 outbreak of Ebola virus disease (EVD) in Liberia resulted in over 10,000 cases and 5,000 deaths. Recognizing the importance of addressing children’s trauma, the Ebola recovery and restoration trust fund (EERTF) funded the implementation of a Comfort for kids (C4K) program which encou...rages psychological healing, and promotes resilience in children who have experienced a crisis or disaster. The C4K program in Liberia was implemented between January 2015 and December 2016 in fifteen townships in Montserrado County through a collaboration between Mercy Corps Liberia, the World Bank’s Liberian health task team, and the government of Liberia. C4K primarily centers on the My Story workbook and associated classroom activities, which provide children with the opportunity to express their emotions about their experiences through drawing, writing, and facilitated discussion. C4K also provides capacity building for parents, teachers, and other caretakers on how to identify and more effectively respond to children’s trauma responses and to support their recovery
more
Ces formulaires sont destinés uniquement aux cliniciens et infirmiers s’occupant de patients atteints de la maladie à virus Ebola. Ils fournissent des informations standardisées qui doivent être collectées par les cliniciens au moment de l’admission, tous les jours, et lors de la sortie du ...patient
more
The mhGAP Humanitarian Intervention Guide (mhGAP-HIG) Training of Health-Care Providers manual is designed to guide facilitators in training non-specialist health care providers to manage mental, neurological and substance use conditions in humanitarian emergency settings.
The manual covers sugge...sted training schedules, learning objectives, and tips for planning and facilitating the training. It also includes step-by-step training modules for different conditions covered in the mhGAP Humanitarian Intervention Guide (mhGAP-HIG).
more
MEDBOX Issue Brief no. 24 (Sept.2022)
On 20 September 2022, Uganda health authorities declared an outbreak of Ebola disease, caused by Sudan virus,
following laboratory confirmation of a patient from a village in Madudu sub-county, Mubende district, central
Uganda.
Therefore the MEDBOX Team cre...ated this issue brief to give a quick overview of the most important documents and training material.
more
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...lness is important.
The living guidance is available in both pdf format (via the ‘Download’ button) and via an online platform in both French and English, and is updated regularly as new evidence emerges.
This first version of the Clinical management for EVD living guidance contains four new recommendations regarding use of therapeutics for EVD, this includes two strong recommendations for the use of monoclonal antibody therapies. This new living guideline is written to accompany the optimized supportive care (oSoC) for EVD standard operating procedures (5, 6). The living guideline aims to summarize high quality evidence for EVD therapeutics and make recommendations for their use.
more
This comprehensive intermediate level course is for clinicians caring for patients with suspected or confirmed Ebola virus disease (EVD). Modules provide information on screening and triage, infection prevention and control, laboratory diagnostics, organization of the Ebola Treatment Centre (ETC), c...linical care of patients in the ETC, and investigational therapeutic agents.
This training course provides clinicians with access to downloadable presentations and posters to facilitate their management of Ebola virus disease (EVD). Under this section, please find a Congolese Swahili translation of all modules with their presentation.
more
Mafunzo haya ya kina ya kiwango wastani ni ya wauguzi wanaowatunza wagonjwa wanaoshukiwa au waliothibitishwa kuwa na ugonjwa wa virusi vya Ebola (EVD). Moduli hii inatoa taarifa ya uchunguzi na ukaguzi, na kuzuia maambukizi and kuthibiti, uchunguzi wa maabara, taratibu za Kituo cha Matibabu ya Ebola... (ETC), uuguzi wa wagonjwa kwenye ETC, uchunguzi wa kimatibabu.sw
more
Aperçu: Cette formation complète de niveau intermédiaire est destinée aux agents de santé de première ligne qui s’occupent de cas suspects ou confirmés de maladie à virus Ebola (MVE). Elle porte sur les domaines suivants : transmission de la MVE (en s’intéressant en particulier aux mesu...res de lutte contre l’infection) ; diagnostic de la maladie ; et prise en charge des cas, avec une présentation générale des centres de traitement d’Ebola (CTE) et des informations sur les traitements expérimentaux. Ces modules présentent des stratégies complètes sur la sécurité des patients et des agents de soins et la préparation à la riposte. La formation pourra être utile aux cliniciens de tout secteur du système de santé, notamment ceux qui travaillent dans des postes de santé, prodiguent des soins de santé primaires ou sont employés par des hôpitaux nationaux ou de district. Une attention particulière est accordée aux soins dispensés dans les CTE.
Objectifs d’apprentissage : À la fin de ce cours, vous serez capable de :
identifier les patients présentant des signes et des symptômes de MVE ;
comprendre la transmission de la MVE ;
comprendre les grands volets de la prise en charge clinique de la MVE ;
connaître les stratégies de lutte contre l’infection;
préparer les établissements, la population et les agents de santé à la riposte à la maladie à virus Ebola ; et
gérer les déchets de façon sécurisée et de procéder à des inhumations sans risque et dans la dignité.
Durée du cours : Environ 8 heures.
Enroll: https://openwho.org/courses/ebola-prise-en-charge-clinique
more
Quarta Edição.
Esta quarta edição do manual se baseia no esquema de avaliação de risco apresentado na terceira edição. Uma avaliação completa, baseada em evidências e transparente dos riscos permite que as medidas de segurança sejam equilibradas com o risco real de trabalhar com agentes... biológicos, caso a caso. Isso permitirá que os países implementem políticas e práticas de biossegurança e biosseguridade laboratoriais economicamente viáveis e sustentáveis que sejam relevantes para suas circunstâncias e prioridades individuais.A necessidade de atualizar as diretrizes de biossegurança de laboratórios internacionais faz parte de uma iniciativa mais ampla para globalizar a biossegurança e enfatizar os princípios e as abordagens que são acessíveis a países que tenham ampla gama de recursos financeiros, técnicos e regulatórios
more
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets trends in biosafety.
LBM encouraged countries t...o accept and implement basic concepts in biological safety and to develop national codes of practice for the safe handling of biological agents in laboratories within their geographical borders.
This fourth edition of the manual builds on the risk assessment framework introduced in the third edition. A thorough, evidence-based and transparent assessment of the risks allows safety measures to be balanced with the actual risk of working with biological agents on a case-by-case basis.
This novel evidence- and risk-based approach will allow optimised resource use and sustainable laboratory biosafety and biosecurity policies and practices that are relevant to their individual circumstances and priorities, enabling equitable access to clinical and public health laboratory tests and biomedical research opportunities without compromising safety.
more
Cette première version des orientations evolutives relatives a la prise en charge clinique de la MVE contient quatre nouvelles recommandations concernant l’utilisation de traitements contre la MVE, y compris deux recommandations fortes en faveur de l’utilisation de thérapies à base d’antico...rps monoclonaux. Ce nouveau document est rédigé en vue d’accompagner des soins de support optimisés (oSoC) pour les procédures opérationnelles standards appliquees a la MVE (5, 6). Les orientations evolutives presentent des preuves de haute qualité concernant l’efficacite des traitements contre la MVE et les recommandations de l’OMS relatives leur utilisation.
more
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Guidance for health care workers.
Guidance for health care workers.